Assessment of Systemic Inflammation and Nutritional Indicators in Predicting Recurrence-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors

Zhenhua Lu, Rui Li, Xianglong Cao, Chengyu Liu, Zhen Sun, Xiaolei Shi, Weiwei Shao, Yangyang Zheng, Jinghai SongFrontiers in Oncology 2021 · DOI

Abstract

High Geriatric Nutrition Risk Index (GNRI) is an independent prognostic factor for recurrence-free survival (RFS) in Gastrointestinal Stromal Tumors (GIST), while the Systemic Immunoinflammatory Index (SII) also serves as a valuable prognostic indicator. These non-invasive tools can evaluate patient prognosis pre-operatively, enabling clinicians to better identify and manage high-risk patients.

Introduction

Gastrointestinal Stromal Tumors (GIST) represent the most prevalent mesenchymal tumors of the digestive tract. While surgical resection remains the gold standard for treatment, post-operative recurrence is a major clinical challenge. Traditional risk stratification, such as the modified National Institutes of Health (mNIH) criteria, focuses primarily on tumor-specific characteristics like size, location, and mitotic index. However, these models often neglect "host" factors—the patient's systemic physiological state.

Emerging research suggests that chronic inflammation and malnutrition significantly influence cancer outcomes. This study investigates the prognostic value of systemic inflammatory and nutritional indices in GIST patients, aiming to provide clinicians with accessible biomarkers for improved risk stratification.

Methods and Patient Cohort

A retrospective analysis was conducted on 160 patients who underwent radical surgery for GIST at Beijing Hospital between 2004 and 2018. The study evaluated several biomarkers:

  • Inflammatory Indices: Systemic Immunoinflammatory Index (SII), Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), and Platelet-to-Lymphocyte Ratio (PLR).
  • Nutritional Indices: Geriatric Nutrition Risk Index (GNRI), Prognostic Nutritional Index (PNI), and Body Mass Index (BMI).

Predictive accuracy was assessed using Area Under the Curve (AUC) analysis. Optimal cutoff values were determined via X-tile software. Survival outcomes were analyzed using Kaplan-Meier curves and Cox regression models. The median follow-up time was 34.5 months.

Comparative Performance of Biomarkers

The study found that systemic indicators vary significantly in their predictive power. Among the nutritional indices, GNRI demonstrated the highest accuracy, while SII outperformed other inflammatory markers.

ROC curves comparing inflammatory (A) and nutritional (B) indices for predicting GIST recurrence.

As shown in Figure 6, GNRI achieved an AUC of 0.713, significantly higher than BMI (0.560). Among inflammatory markers, SII (AUC=0.650) and NLR (AUC=0.644) were the most effective.

Key Findings and Clinical Implications

Multivariate analysis confirmed that GNRI (Hazard Ratio [HR] = 2.802), along with tumor location, size, and mitotic index, are independent prognostic factors for RFS. Patients with a "High GNRI" (>98.3) exhibited a 5-year RFS rate of 91.96%, compared to only 60.19% in the "Low GNRI" group.

While GNRI is a robust long-term predictor, SII showed particular strength in short-term prognosis.

ROC curve for 1-year recurrence-free survival, highlighting the high predictive accuracy of SII.

In Figure 5, the AUC for SII at 1 year reached 0.826, suggesting it is a highly sensitive tool for identifying patients at risk of early recurrence. SII was also notably effective in differentiating outcomes for "intermediate risk" patients under traditional staging, where clinical decision-making is often most complex.

Conclusion

This study highlights that a patient's systemic nutritional and inflammatory status is a critical, independent predictor of GIST recurrence. GNRI and SII offer simple, non-invasive methods to enhance traditional risk models. Integrating these "host" factors allows for a more holistic risk profile, potentially guiding more intensive post-operative monitoring or adjuvant therapies like Tyrosine Kinase Inhibitors (TKIs).

Future multi-center prospective studies are needed to validate these thresholds and further explore the interaction between these markers and rare clinical events like tumor rupture.

Summary updated

Abstract

High GNRI is an independent prognostic factor for RFS in GIST, while SII can be considered as a prognostic factor. GNRI and SII can be used as tools to evaluate the prognosis of patients before surgery, helping doctors to better treat high-risk patients.
BibTeX
@inproceedings{lu2021assessment,
  author = {Zhenhua Lu and Rui Li and Xianglong Cao and Chengyu Liu and Zhen Sun and Xiaolei Shi and Weiwei Shao and Yangyang Zheng and Jinghai Song},
  title = {{Assessment of Systemic Inflammation and Nutritional Indicators in Predicting Recurrence-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors}},
  booktitle = {Frontiers in Oncology},
  year = {2021},
  doi = {10.3389/fonc.2021.710191},
}
Figure